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http://dx.doi.org/10.1016/j.stemcr.2016.08.005SUMMARYHuman erythro-megakaryopoiesis does not occur in humanizedmousemodels, preventing the in vivo analysis of human hematopoietic
stem cell (HSC) differentiation into these lineages in a surrogate host. Here we show that stably engrafted KIT-deficient NOD/SCID
Il2rg/ KitW41/W41 (NSGW41) mice support much improved human erythropoiesis and platelet formation compared with irradiated
NSG recipients. Considerable numbers of human erythroblasts and mature thrombocytes are present in the bone marrow and blood,
respectively. Morphology, composition, and enucleation capacity of de novo generated human erythroblasts in NSGW41 mice are
comparable with those in human bone marrow. Overexpression of human erythropoietin showed no further improvement in human
erythrocyte output, but depletion of macrophages led to the appearance of human erythrocytes in the blood. Human erythropoiesis
up to normoblasts and platelet formation is fully supported in NSGW41 mice, allowing the analysis of human HSC differentiation
into these lineages, the exploration of certain pathophysiologies, and the evaluation of gene therapeutic approaches.INTRODUCTION
Erythrocytes are essential for oxygen supply, and anemia
can have severe systemic consequences. The causes of ane-
mia include iron deficiency/blood loss, cancer, infectious
disease, and genetic disorders such as sickle cell anemia or
thalassemia. Analysis of mechanisms leading to anemia is
severely limited by the lack of appropriate in vivo models
(Pishesha et al., 2014). Also, the generation of functional
platelets in humanized mouse models is challenging.
Abnormal platelet generation and function cause bleeding
disorders and evoke thrombotic and cardiovascular dis-
eases that are potential causes of mortality (Massberg
et al., 2002). To date, the ex vivo generation of platelets
from donor-independent or autologous sources has been
hampered by an incomplete understanding ofmechanisms
promoting platelet differentiation and maturation (Kara-
giannis and Eto, 2015; Lambert et al., 2013). Finally, it is
impossible to test for differentiation of these lineages
in vivo (Mende et al., 2016), underlining the need for suit-
able in vivo models to study these processes.
Many immunodeficient mouse models receptive for
transplantation of human hematopoietic stem cells (HSCs)
have been developed over the last decade to support the
engraftment and differentiation of specific hematopoietic
lineages (Cosgun et al., 2014; Chen et al., 2009; RongvauxStem Cell R
This is an open access article under the Cet al., 2014). However, in all mouse models available to
date human erythropoiesis is severely impaired. In contrast,
human platelets can develop and mature in humanized
mouse models, but their output is generally very low (Hu
and Yang, 2012; Rongvaux et al., 2011; Suzuki et al.,
2007). Clearance of human red blood cells (RBCs) bymacro-
phagesafter infusion intoCD47-deficientmice suggests that
absence of RBCs and their immediate progenitors is due to
signal-regulatory protein alpha (SIRPalpha)-independent
phagocytic activity (Hu et al., 2011). Furthermore, macro-
phage depletion or overexpression of human interleukin-3
(IL-3) and human erythropoietin (hEPO) lead to the tran-
sient appearance of low numbers of human RBCs in the
blood of humanized mice (Hu et al., 2011; Chen et al.,
2009). Also, thrombocyte reconstitution in the blood can
be further improved by treatment with clodronate lipo-
somes or pegylated recombinant human megakaryocyte
growth anddevelopment factor (Hu andYang, 2012; Suzuki
et al., 2007). However, due to the transient nature of the in-
crease of human RBCs and human platelets in all models,
the use of humanizedmousemodels to study human eryth-
rocyte differentiation is severely limited.
We generated mouse strains suitable for humanization
by introducing loss-of-function KIT receptors (W41 or Wv
alleles) into NOD/SCID Il2rg/ (NSG; NSGW41, NSGWv)
or BALB/c Rag2/ Il2rg/ (BRgWv) mice (Cosgun et al.,eports j Vol. 7 j 591–601 j October 11, 2016 j ª 2016 The Authors. 591
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2014). These mice efficiently support stable engraftment of
human hematopoietic stem and progenitor cells (HSPCs)
in the long term without the need for previous condition-
ing therapy, and were instrumental for the study of effects
of cell physiological processes on human HSC function
in vivo (Mende et al., 2015). A second striking feature is
the remarkably increased engraftment of human myeloid
cells in bone marrow (BM) and spleen, evidencing that sta-
ble stem cell engraftment is sufficient to ensure continuous
output of human myeloid cells (Cosgun et al., 2014; Rah-
mig et al., 2015). In BRgWv mice, low frequencies of hu-
man erythroid cells were detected in the BM (Cosgun
et al., 2014), suggesting that RBC generation may occur
in humanized KIT-mutant recipient mice. Here, we show
the efficient differentiation of human donor HSPCs into
erythroblasts/normoblasts and megakaryocytes in human-
izedNSGW41 recipients comparedwith conventional NSG
recipients, suggesting that growth factors responsible for
these differentiation paths are compatible across species.
Mature human RBCs are absent and low numbers of hu-
man platelets are found in the blood, but macrophage
depletion transiently restores erythrocyte and platelet re-
population. The entire differentiation from human HSCs
into RBCs and platelets is recapitulated in the murine
BM, providing an in vivo setting that allows for the study
of the regulation of RBC and platelet formation in health
and disease.RESULTS AND DISCUSSION
Human Erythropoiesis in NSGW41 Recipients
Transplantation of human CD34-enriched cord blood (CB)
cells results in enhanced and uniform engraftment of hu-
man leukocytes in the blood (Figure 1A) and BM (FiguresFigure 1. Improved Human Erythroid Engraftment in NSGW41 Mi
(A and B) Human leukocyte chimerism (top) and composition of hum
experiments, 2–5 mice per experiment; and (B) in the BM of NSG an
ments, 2–4 mice per experiment.
(C) Immunofluorescence of human and mouse CD45+ cells in bone se
(D) Colony assays. Two experiments, 2–5 mice per experiment, two t
(E) Blood parameters of non-transplanted (open) and transplante
(>26 weeks, closed) after humanization. There is no discrimination bet
experiment.
(F) Survival plot after humanization. Twenty experiments, 3–16 mice
(G) RBC chimerism.
(H) Frequency (top) and number per two femura (bottom) of CD23
experiment.
(I) Human erythroid precursors.
(J) Giemsa-stained cells sorted as shown in (I). Scale bar, 12 mm.
(K) Frequencies (left) and numbers (right) of cells of human origin
humanized mice. Seven experiments, 2–9 mice per experiment.
Data represent means ± SD. *p = 0.05–0.01, **p = 0.01–0.001, ***p1B and 1C) of NSGW41 recipients compared with irradi-
ated NSG mice. Colony formation confirmed the presence
of increased numbers of lineage-specific progenitors in hu-
manized NSGW41 mice compared with controls (Fig-
ure 1D), evidencing improved engraftment of human
HSPCs. To test whether cell-intrinsic impairment ofmurine
erythropoiesis (Sharma et al., 2007) provides an advantage
for human RBC differentiation, we compared blood cell pa-
rameters between non-transplanted and humanized mice
(Figure 1E). Non-transplanted NSGW41 mice display a
macrocytic anemia (Sharma et al., 2007). After humaniza-
tion, RBC parameters decreased in both recipients but
were more pronounced in NSGW41 mice. Despite the se-
vere anemia in NSGW41 mice, the survival between both
humanized mouse strains was comparable (Figure 1F).
Neither conditioned NSG nor unconditioned NSGW41
mice showed human RBCs in the circulation (Figure 1G).
In contrast, the BM of NSGW41 mice was highly repopu-
lated with human erythroid progenitor cells (Figures 1G
and 1H) that were present only at low frequencies in the
donor cells (Figure S1D), suggesting that stable human
HSC engraftment supports an increased output of cells of
the erythroid lineage. Consistent with this interpretation
is the fact that the transplantation of sorter-purified human
HSCs also results in the engraftment of human erythro-
blasts in the BM of KIT-mutant recipient mice (Koichi Aka-
shi, personal communication).
To assess for a specific block of differentiation due to a po-
tential incompatibility for human RBC differentiation in
the murine environment, we quantified erythroid precur-
sors (pro-E, Int-E/Late-E, Retic/RBC, Figures 1I and 1J). All
differentiation stages were present, and increased numbers
of human RBC progenitors were detected in humanized
NSGW41 compared with NSG recipients (Figures S1C and
1K), suggesting that human erythropoiesis is stronglyce
an graft (bottom): (A) in the blood at indicated time points, five
d NSGW41 recipients 24–32 weeks after humanization, five experi-
ctions of NSG and NSGW41 recipients. Scale bar, 100 mm.
echnical replicates each.
d NSG and NSGW41 mice early (<12 weeks, half-filled) and late
ween human and mouse parameters. Five experiments, 2–8 mice per
per experiment.
5+ cells within all erythrocytes. Seven experiments, 2–9 mice per
within all erythroid cells of the indicated differentiation stage in
< 0.001; n.s., not significant. See also Figure S1.
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Figure 2. Overexpression of Human Erythropoietin in NSGW41 Mice
(A) Generation of NSGW41 hEPO-tg mice.
(B) Human (left) and murine (right) blood EPO levels in indicated mice and human controls (hPB). human EPO: two experiments, 3–6
replicates each; mouse EPO: one experiment, 4–6 replicates each.
(C) Human leukocyte chimerism (left) and donor cell composition in the blood (right). Four experiments, 2–4 mice per experiment.
(D) BM leukocyte chimerism (left) and graft composition (right) 25–32 weeks after humanization. Four experiments, 1–3 mice per
experiment.
(legend continued on next page)
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supported in NSGW41mice. Engraftment of human eryth-
roblasts/normoblasts in NSGW41 occurred at the ex-
pense of endogenous erythroid progenitors (Figures S1A
and S1B), resulting in a more pronounced anemia in
NSGW41 mice. We conclude that stable human HSC
engraftment is a prerequisite for continuous human eryth-
ropoiesis in mice, and commitment to the erythroid line-
age and differentiation up to nucleated erythroid progeni-
tor stages is supported by themurinemicroenvironment in
NSGW41 recipients.
Overexpression of Human Erythropoietin Fails to
Enhance Human RBC Engraftment
The injection of hEPO- and IL-3-encoding plasmids into
humanized NSG mice results in the appearance of low fre-
quencies of human CD235+ erythrocytes in the blood
(Chen et al., 2009). To test whether the overexpression of
hEPO (Waskow et al., 2002, 2004) in NSGW41 mice in-
creases RBC reconstitution, we generated NSGW41 hEPO-
transgenic (hEPO-tg) mice (Figure 2A). Increased plasma
hEPO levels were confirmed before and after humanization
(Figure 2B). NSGW41 mice, comparable with Kit mutants
in other genetic backgrounds (Waskow et al., 2004), dis-
played 8-fold higher mouse EPO levels in response to the
endogenous anemia (Geissler et al., 1981). hEPO levels in
NSGW41 hEPO-tg mice were 50-fold elevated compared
with human blood. Human donor cell chimerism was
reduced in the blood and BM of NSGW41 hEPO-tg mice
compared with NSGW41 mice (Figures 2C and 2D), sug-
gesting that hEPO induces differentiation of donor HSPCs
and prevents their efficient engraftment. However, hEPO
had no effect on the composition of human white blood
cells (Figures 2C and 2D). RBC parameters were signifi-
cantly increased in non-transplanted NSGW41 hEPO-tg
mice, evidencing the functionality of the surplus hEPO,
but after humanization RBC counts and hemoglobin con-
tents still significantly decreased in bothmouse strains (Fig-
ure 2E). The number of murine erythroblasts/normoblasts
decreased equally in humanized NSGW41 hEPO-tg or
NSGW41 mice (Figures 2F and S1B). Regardless, the
engraftment of human erythroblasts in BM of humanized
NGSW41 hEPO-tg mice was reduced compared with
NSGW41 mice (Figure 2G) and no mature human RBCs
were found in the blood of recipients. This evidences a
lack of support for human erythroid engraftment by
hEPO overexpression. EPO supports RBC differentiation
in mice and humans at late stages during erythroid differ-(E) Blood parameters in NSGW41 and NSGW41 hEPO-tg mice with (31 w
mice).
(F) Mouse RBC precursors per two femura. Four experiments, 1–3 mic
(G) Human RBC precursors per two femura. Four experiments, 1–3 mi
Data represent means ± SD. *p = 0.05–0.01, **p = 0.01–0.001, ***pentiation by promoting erythroblast proliferation and in-
hibiting apoptosis (Kaushansky, 2006; Waskow et al.,
2004). However, intermediate and late stages of erythroid
differentiation are particularly well repopulated by cells
of human origin in NSGW41 mice (Figures 1G–1K), sug-
gesting a defect at or beyond the enucleation of human
RBC precursors.
Depletion of Macrophages Partially Rescues
Erythrocyte Maturation
Phagocytosis has been considered an alternative cause for
lack of human RBCs in humanized mice (Hu et al., 2011).
Endogenous murine macrophages are reduced after hu-
manization (Figure S2A) but remain phagocytically active
(Figure S2B). To deplete macrophages we injected clodro-
nate-containing liposomes (CloLip) (Figure 3A), which
cleared phagocytes from the blood ((Hu et al., 2011), Fig-
ures 3B and 3C) and resulted in the appearance of human
RBCs in the circulation of humanized NSGW41 mice (Fig-
ures 3B and 3D). Correspondingly, the composition of
human BM erythroid cells was altered and the frequency
of Int-E/Late-E cells (CD71+ CD235+) was significantly
reduced, whereas CD235+ Retic/RBCs increased (Figure 3E).
We conclude that the depletion of macrophages improves
human erythrocyte reconstitution in the blood of
humanized mice but the shift toward more mature
erythroid cells is incomplete, perhaps due to a block within
Int-E/Late-E erythroblasts/normoblasts that contain termi-
nal differentiation stages prior to enucleation, or insuffi-
cient enucleation.
Human Erythroblasts Generated inNSGW41Mice Can
Terminally Differentiate
The composition of CD71+ CD235+ progenitors that
contain pro- and basophilic erythroblasts, polychromato-
philic and orthochromatic normoblasts, and reticulocytes
was comparable between humanized NSGW41, NSGW41
hEPO-tg, and human BM (Figure 3F), evidencing normal
erythroid differentiation in our mouse strains. Further-
more, human CD71+ CD235+ Int-E/Late-E erythroblasts
fromhuman orNSGW41 BM enucleated at comparable fre-
quencies (Figure 3G), suggesting that human erythroblasts
generated in mice can efficiently enucleate. However, we
cannot formally exclude that the enucleation frequency
in vivo differs between humanized mice and human BM
because the formation of erythroblastic islandsmay require
factors that are incompatible between the species (Dzierzakeeks, one experiment, 2–3 mice) and without humanization (7–10
e per experiment.
ce per experiment.
< 0.001; n.s., not significant.
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and Philipsen, 2013). Adult globin chain gene expression
was detected in CD71+ CD235+ cells from humanized
mice, but the majority of transcripts encoded for fetal he-
moglobin subunits (g-globin) in all humanized mice (Fig-
ure 3H). However, humanized NSGW41 mice expressed
increased amounts of transcripts encoding for adult-type
b-globin. Furthermore, d-globin, which is part of adult
HbA2 hemoglobin, was not expressed in human CB but
in all humanized mice, evidencing a globin switch in CB-
derived erythroblasts. However, while silencing of g-globin
is not observed, b-globin activation seems to occur, suggest-
ing that a globin switch is at least partially realized in hu-
manized mice (Bauer and Orkin, 2011). The expression of
fetal globin should not pose a problem to the final matura-
tion and functionality of human erythrocytes in mice, as
patients with a certain type of hereditary persistence of
fetal hemoglobinwhohave 100% fetal hemoglobin display
no anemia (Bauer and Orkin, 2011). We conclude that
there is no block in human erythrocyte maturation in
NSGW41mice and assign paucity of human RBCs to either
insufficient in vivo enucleation or SIRPalpha-independent
phagocytosis.
Human Platelet Formation Is Improved
in NSGW41 Mice
The reconstitution of human thrombocytes is severely
impaired in humanized mouse models (Hu and Yang,
2012; Rongvaux et al., 2011; Suzuki et al., 2007). Non-
transplanted NSGW41 mice display thrombocytopenia
(Figure 4A). After transplantation thrombocytes decreased
in irradiated NSG and NSGW41 mice, but the decline was
accelerated and more severe in NSGW41 mice. After hu-
manization, mature human megakaryocytes were present
in NSGW41 and NSG mice (Figure 4B), but the frequency
was much improved in NSGW41 compared with NSG re-
cipients (Figure 4D). Consistently, hCD61+ platelets were
present in higher frequencies in BM and blood of human-
ized NSGW41 mice (Figures 4C and 4D). Despite a signifi-Figure 3. Terminal Erythroid Differentiation Is Not Impaired in E
(A) Scheme of macrophage depletion by CloLip 11 to 21 weeks after
(B) Representative pictures of macrophage depletion.
(C) Frequencies of murine CD11b+ Gr-1lo macrophages in the blood of h
not treated. Two experiments, 2–4 mice per experiment.
(D) Frequencies (top) and numbers (bottom) of human CD235+ cells
(E) Human BM erythroblasts/normoblasts 6–8 days after CloLip. One
(F) Giemsa-stained human RBC maturation stages within hCD71+ CD23
BM from humanized NSGW41 mice (n = 5), and NSGW41 hEPO-tg mic
(G) In vitro enucleation assay. Pictures from hCD71+ CD235+ erythroid
of enucleated cells, 162–248 cells per cytospin counted. Three exper
(H) Scheme of human globin expression during development. Semi-
hCD71+ CD235+ cells.
Data represent means ± SD. *p = 0.05–0.01, **p = 0.01–0.001, ***pcant improvement of human thrombocyte reconstitution
in NSGW41 mice, the frequency of circulating platelets
was still low compared with overall human chimerism (Fig-
ure 1A). Macrophage depletion resulted in an increase of
human platelets in the blood (Figure 4E). Quantification
of thrombocytes in the BM showed no difference between
macrophage-depleted and control mice (Figure S3), sug-
gesting that megakaryocyte/thrombocyte lineage commit-
ment and maturation were not affected by macrophage
depletion but that survival in the periphery was enhanced.
We conclude that maturation and survival of human
thrombocytes are increased in NSGW41 mice compared
with irradiated NSG mice.
Our results show that stable human HSC engraftment is
sufficient to support the generation and maturation of
human erythrocytes, thrombocytes, and other myeloid
cells (Cosgun et al., 2014). The increased engraftment
of human cells in NSGW41 mice occurs at the expense
of murine erythroblasts and megakaryocytes, suggesting
replacement of endogenous hematopoiesis. We conclude
that NSGW41 mice are an improved tool for the study
of human erythrocytes and RBC-associated diseases.
Despite the presence of high numbers of human erythro-
blasts/normoblasts in the BM of NSGW41 mice, we could
only detect human erythrocytes in the circulation after
macrophage depletion. Significant differences between
human and mouse erythropoiesis were reported (An
et al., 2014; Pishesha et al., 2014) but direct comparisons
are difficult, as murine erythroblasts are usually isolated
from BM whereas human erythroblasts are derived from
in vitro culture of CD34+ cells (Palis, 2014). We show
here that there is no differentiation defect in the newly
generated human erythroblasts, enucleation can take
place, and even a partial globin chain switch occurs in
mice, suggesting that growth factors important in RBC dif-
ferentiation are cross-reactive between humans and mice.
We reason that the murine NSGW41 environment en-
ables human erythrocyte and thrombocyte differentiationrythroblasts Generated in Mice
humanization.
umanized NSGW41 mice that have received CloLip 24 hr before. n.t.,
in the blood. Two experiments, 2–4 mice per experiment.
experiment, four mice.
5+ cells. Composition of hCD71+ CD235+ cells in human BM (n = 3),
e (n = 3). Two experiments, 110 cells counted on each cytospin.
cells after 7 days of culture. Scale bar, 20 mm. Right: quantification
iments, 1–2 replicates per experiment.
quantitative analysis of human globin mRNA expression in sorted
< 0.001. See also Figure S2.
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without additional manipulation, allowing for the in vivo
analysis of human erythropoiesis.EXPERIMENTAL PROCEDURES
Mice
NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJmice (NSG)were obtained from the
Jackson Laboratory. NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ KitW41/W41
mice (NSGW41) were generated as previously described (Cosgun
et al., 2014). To generate NSGW41 hEPO-tg mice, we backcrossed
Tg6 mice (C57BL/6), which constitutively overexpress hEPO in a
hypoxia-independent manner and show hematocrit values of up
to 80% (Vogel and Gassmann, 2011), ten times onto NSG. Subse-
quently, NSG hEPO-tg mice were crossed with NSGW41 animals.
All mice were bred and maintained under specific pathogen-free
conditions at the animal facility of the TU Dresden. Animal exper-
iments were performed in accordance with German animal welfare
legislation and approved by the relevant authorities (Landesdirek-
tion Dresden, Referat 24).
Human Donor Cells
Human umbilical CB samples were provided by the DKMS Cord
Blood Bank, Dresden. Human BM samples were obtained from
healthy BM donors in the Department of Hematology/Oncology
of the University Hospital, Dresden. All human samples were
used in accordance with the guidelines approved by the Ethics
Committee of the Dresden University of Technology.
Transplantations
CD34+ progenitor cells were isolated from human CB as described
previously (Cosgun et al., 2014). For humanization 53 104 CD34-
enriched cells were injected intravenously in 150 mL of PBS/5%
fetal calf serum into 4- to 12-week-old conditioned NSG (200
cGy; MaxiShot, Yxlon) or unconditioned NSGW41 or NSGW41
hEPO-tg mice. After transplantation, mice were given neomycin-
containing drinking water for 3 weeks.
Blood Analysis
For complete blood counts, blood of mice was collected in EDTA-
containing microtubes. Blood samples were diluted in a ratio of
1:5 with NaCl 0.9% and analyzed on a Sysmex XT2000iV or Sys-
mex XE-5000 blood analyzer.Figure 4. Human Thrombopoiesis in NSGW41 Mice
(A) Blood parameters of NSG and NSGW41 mice with and without hum
distribution width. No discrimination between human and mouse par
(B) Immunofluorescence of human megakaryocytes in human BM cyto
NSG mice. Scale bar, 20 mm.
(C) Expression of mCD41 and hCD61 on forward scatter low (FSClo), T
(D) Frequency of human megakaryocytes (FSChi hCD45 hCD61+) within
or hCD61+) (five experiments, 2–4 mice per experiment) and frequency
experiment) or blood platelets (four experiments, 1–4 mice per expe
(E) Human platelets in the blood of humanized NSGW41 mice 6 days a
experiment.
Data represent means ± SD. *p = 0.05–0.01, **p = 0.01–0.001, ***pFlow Cytometry and Cell Sorting
BM and blood samples were collected and prepared as described
previously (Cosgun et al., 2014). Samples were acquired on an
LSRII cytometer (BD Biosciences) or a MACS Quant Analyzer (Mil-
tenyi) and analyzed using FlowJo software (TreeStar). Sorting of hu-
man erythrocyte populationswas performed on a FACSAria II or III
(BDBiosciences). For determining total cell numbers, a specific vol-
ume of the respective cell suspension was analyzed on a MACS
Quant Analyzer. Details regarding antibodies can be found in Sup-
plemental Experimental Procedures.Colony Assay
Human CD45+ cells (5 3 104) were sorted from BM of humanized
NSG and NSGW41mice or fresh human BM samples and plated in
duplicate into a 6-well plate with methylcellulose-containing me-
dium supplemented with rhSCF, rhGM-CSF, rhG-CSF, rhIL-3, and
rhEPO (MethoCult GF H84434; STEMCELL Technologies). After
14 days the number and types of colonies was analyzed using a
STEMvision instrument (STEMCELL).Enucleation Assay
Sorter-purified hCD71+CD235+ BMcells (4.83 105 to 13106) from
humanized NSGW41 mice or fresh human BM samples were
seeded in 1 mL of Iscove’s modified Dulbecco’s medium supple-
mented with 1% L-glutamine, 100 U/mL penicillin, 100 mg/mL
streptomycin, 330 mg/mL holo-human transferrin, 10 mg/mL re-
combinant human insulin, 2 IU/mL heparin, and 5% pooled AB
serum (German Red Cross Blood Donation Service North-East),
and 3 U/mL human erythropoietin into 24-well plates (Giarratana
et al., 2011). Mediumwas renewed after 3 days. On day 7 cells were
collected, and 23 105 to 53 105 cells were cytospun and analyzed.Morphological Analysis
Sorted BM or cultured cells were cytospun onto polylysine-coated
slides at 25–100 3 g for 5 min and after ON drying stained with
May-Gruenwald-Giemsa. Photographs were taken using Nikon
Eclipse TS100 or Keyence BZ9000 microscopes.Macrophage Depletion
Macrophages were depleted by intravenous injection of 200 mL
of clodronate liposomes (ClodronateLiposomes.com). Controls
received 200 mL of PBS. Macrophage depletion was confirmedanization. Plt, platelet; MPV, mean platelet volume; PDW, platelet
ameters. Five experiments, 2–8 mice per experiment.
spins and sections of bones from humanized NSGW41 and irradiated
er119 CD235, h + m CD45 BM (top), and blood (bottom) cells.
all megakaryocytes (FSChi, Ter119 CD235, h + m CD45, mCD41+,
of human platelets within all BM (seven experiments, 1–4 mice per
riment).
fter macrophage depletion (CloLip). Two experiments, 2–4 mice per
< 0.001; n.s., not significant. See also Figure S3.
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24 hr and red blood cell appearance 1–8 days after injection by flow
cytometry.
EPO ELISA
Human or murine EPO levels were quantified from plasma or
serum, respectively, using specific ELISAs (Quantikine; R&D Sys-
tems) according to the manufacturer’s guidelines. For details on
sample preparation see Supplemental Experimental Procedures.
Globin Chain Expression
For RNA isolation (RNeasyMicroKit, Qiagen) 4.43 104 to 8.33 105
hCD71+ CD235+ cells were sorted from BM of humanized NSG,
NSGW41 and NSGW41 hEPO-tg mice, fresh human BM samples,
or CB. cDNA was synthesized with the SuperScript First-Strand
Synthesis System (Invitrogen). Semi-quantitative PCR was per-
formed by titrating the number of amplification cycles. Primer
sequences and number of amplification cycles are provided in Sup-
plemental Experimental Procedures.
Immunohistochemistry
Fifteen weeks after humanization, cryosections from humeri were
cut (3 mm) from paraformaldehyde-fixed, decalcified bones on
a Cryotome CM1900 using the CryoJane Tape-Transfer System
(Leica). Samples were analyzed by a fluorescence microscope
(BZ-9000E; Keyence) and images were processed by BZ-Analyzer
II software (Keyence) or Adobe Photoshop CS5 (Adobe). Details
regarding antibodies can be found in Supplemental Experimental
Procedures.
Statistical Analysis
Two-tailed Student’s t tests were performed for all statistical
analyses using Prism 5 for MacOSX software. In all graphs *p =
0.05–0.01, **p = 0.01–0.001, and ***p < 0.001; data represent the
mean ± SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and three figures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.stemcr.2016.08.005.
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